ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.492,49
1,22%
S&P 500
5.459,10
1,11%
US Dollar vs BRL
5,647
-0,16%
Bitcoin
68.383,47
0,69%
Brent Oil
79,745
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ReShape Lifesciences Inc (RSLS)

  7. ReShape Lifesciences Inc (RSLS) Notícias

RSLS

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RSLS
DataHoraFonteTítuloCódigoCompanhia
09/07/202413:13GlobeNewswire Inc.Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”NASDAQ:RSLSReShape Lifesciences Inc
09/07/202410:22Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RSLSReShape Lifesciences Inc
09/07/202410:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
09/07/202409:31GlobeNewswire Inc.ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad MedisysNASDAQ:RSLSReShape Lifesciences Inc
15/05/202417:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
15/05/202417:05GlobeNewswire Inc.ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
14/05/202409:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
01/04/202417:05GlobeNewswire Inc.ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
28/03/202409:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
04/03/202410:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
22/02/202410:31GlobeNewswire Inc.ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
24/01/202410:31GlobeNewswire Inc.ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
16/01/202420:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RSLSReShape Lifesciences Inc
05/01/202418:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RSLSReShape Lifesciences Inc
20/12/202310:31GlobeNewswire Inc.ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership AlternativesNASDAQ:RSLSReShape Lifesciences Inc
12/12/202318:05GlobeNewswire Inc.ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
21/11/202310:06GlobeNewswire Inc.ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross ProceedsNASDAQ:RSLSReShape Lifesciences Inc
08/11/202318:05GlobeNewswire Inc.ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction PlanNASDAQ:RSLSReShape Lifesciences Inc
06/11/202310:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
03/10/202310:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RSLSReShape Lifesciences Inc
29/09/202313:30GlobeNewswire Inc.ReShape Lifesciences® Announces Pricing of $3.0 Million Public OfferingNASDAQ:RSLSReShape Lifesciences Inc
27/09/202318:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
22/09/202309:31GlobeNewswire Inc.ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVINASDAQ:RSLSReShape Lifesciences Inc
21/09/202309:31GlobeNewswire Inc.ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
19/09/202309:31GlobeNewswire Inc.ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
14/09/202309:31GlobeNewswire Inc.ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceNASDAQ:RSLSReShape Lifesciences Inc
25/08/202317:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RSLSReShape Lifesciences Inc
07/08/202317:05GlobeNewswire Inc.ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
03/08/202317:05GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
29/06/202309:31GlobeNewswire Inc.ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization SoftwareNASDAQ:RSLSReShape Lifesciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RSLS

Seu Histórico Recente

NASDAQ
AAYPUXX
Bank of Montreal Itm Dig...
USOTC
KMYGY
Kumyang (QX)
USOTC
FRSAF
First Au (PK)
BIT
F33602
Vontobel Financial Produ...
BIT
F34686
Vontobel Financial Produ...
EU
GVOLT
Greenvolt Energias Renov...
EU
ALPM
Precia
NASDAQ
AAYSWXX
Barclays Bank Plc Autoca...
ASX
PUROA
Pursuit Minerals
ASX
MIOR
Macarthur Minerals
ASX
FTT
Factor Therapeutics
ASX
AZY
Antipa Minerals
BIT
F39070
Vontobel Financial Produ...
USOTC
ALKN
Alkane (CE)
BMF
DIIV25V26
DIIV25V26 - 10/2025
DOWI
DJCIAGCP
DJ Commodity Index Agric...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados